tiprankstipranks
Advertisement
Advertisement

SRRK Stock Latest News

Scholar Rock Readies for Apitegromab Launch Amid Risks
Company AnnouncementsScholar Rock Readies for Apitegromab Launch Amid Risks
2d ago
SRRK
Scholar Rock: Strengthened Regulatory Path and Cash Position Underscore Attractive Risk‑Reward Ahead of Apitegromab PDUFA
PremiumRatings
Scholar Rock: Strengthened Regulatory Path and Cash Position Underscore Attractive Risk‑Reward Ahead of Apitegromab PDUFA
5d ago
SRRK
Scholar Rock to remove Catalent Indiana facility from apitegromab BLA
PremiumThe Fly
Scholar Rock to remove Catalent Indiana facility from apitegromab BLA
8d ago
NVO
SRRK
Scholar Rock price target raised to $76 from $70 at BMO Capital
PremiumThe Fly
Scholar Rock price target raised to $76 from $70 at BMO Capital
8d ago
SRRK
Scholar Rock price target raised to $60 from $58 at Citi
PremiumThe Fly
Scholar Rock price target raised to $60 from $58 at Citi
8d ago
SRRK
Scholar Rock: Buy Rating Reiterated as Apitegromab Advances Toward PDUFA; $65 Price Target Maintained
PremiumRatingsScholar Rock: Buy Rating Reiterated as Apitegromab Advances Toward PDUFA; $65 Price Target Maintained
8d ago
SRRK
Scholar Rock Expands $200 Million At-The-Market Program
Premium
Company Announcements
Scholar Rock Expands $200 Million At-The-Market Program
9d ago
8K
SRRK
Scholar Rock reports Q2 EPS (84c), consensus (84c)
Premium
The Fly
Scholar Rock reports Q2 EPS (84c), consensus (84c)
9d ago
SRRK
Scholar Rock provides update on timing of CHMP opinion for apitegromab MAA
PremiumThe Fly
Scholar Rock provides update on timing of CHMP opinion for apitegromab MAA
26d ago
NVO
SRRK
Scholar Rock Shareholders Reaffirm Board, Governance and Oversight
PremiumCompany Announcements
Scholar Rock Shareholders Reaffirm Board, Governance and Oversight
2M ago
8K
SRRK
Scholar Rock Charts High-Stakes Path to SMA Launch
PremiumCompany Announcements
Scholar Rock Charts High-Stakes Path to SMA Launch
3M ago
SRRK
Scholar Rock Charts Path to Apitegromab Approval
PremiumCompany Announcements
Scholar Rock Charts Path to Apitegromab Approval
3M ago
SRRK
JPMorgan places Scholar Rock on ‘Positive Catalyst Watch’
PremiumThe FlyJPMorgan places Scholar Rock on ‘Positive Catalyst Watch’
3M ago
SRRK
Scholar Rock price target raised to $55 from $53 at Barclays
Premium
The Fly
Scholar Rock price target raised to $55 from $53 at Barclays
3M ago
SRRK
Scholar Rock price target raised to $65 from $58 at H.C. Wainwright
Premium
The Fly
Scholar Rock price target raised to $65 from $58 at H.C. Wainwright
3M ago
SRRK
Scholar Rock reports Q1 EPS (83c), consensus (78c)
PremiumThe Fly
Scholar Rock reports Q1 EPS (83c), consensus (78c)
3M ago
SRRK
Scholar Rock Advances Apitegromab Toward Potential 2026 Launches
PremiumCompany Announcements
Scholar Rock Advances Apitegromab Toward Potential 2026 Launches
3M ago
8K
SRRK
Scholar Rock initiated with a Buy at Canaccord
PremiumThe Fly
Scholar Rock initiated with a Buy at Canaccord
4M ago
SRRK
Scholar Rock initiated with a Buy at Canaccord
PremiumThe Fly
Scholar Rock initiated with a Buy at Canaccord
4M ago
SRRK
Scholar Rock price target raised to $57 from $54 at Jefferies
PremiumThe FlyScholar Rock price target raised to $57 from $54 at Jefferies
5M ago
SRRK
De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab
Premium
Ratings
De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab
5M ago
SRRK
Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
5M ago
UL
AMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >